NDC 57278-315
Triferic
Ferric Pyrophosphate Citrate
Triferic is a Intravenous Powder in the Human Prescription Drug category. It is labeled and distributed by Rockwell Medical, Inc. The primary component is Ferric Pyrophosphate Citrate.
| Product ID | 57278-315_698459af-84e6-55f5-e053-2a91aa0aac82 |
| NDC | 57278-315 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Triferic |
| Generic Name | Ferric Pyrophosphate Citrate |
| Dosage Form | Powder |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2016-04-25 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208551 |
| Labeler Name | Rockwell Medical, Inc |
| Substance Name | FERRIC PYROPHOSPHATE CITRATE |
| Active Ingredient Strength | 272 mg/1 |
| Pharm Classes | Iron [CS],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
Packaging
NDC 57278-315-02
100 PACKET in 1 CARTON (57278-315-02) > 1 POWDER in 1 PACKET
| Marketing Start Date | 2016-04-25 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 57278-315-02 [57278031502]
Triferic POWDER
| Marketing Category | NDA |
| Application Number | NDA208551 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2016-04-25 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| FERRIC PYROPHOSPHATE CITRATE | 272 mg/1 |
OpenFDA Data
| SPL SET ID: | 46ec9233-4063-4c48-e054-00144ff8d46c |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Pharmacological Class
- Iron [CS]
- Parenteral Iron Replacement [EPC]
- Phosphate Binder [EPC]
- Phosphate Chelating Activity [MoA]
NDC Crossover Matching brand name "Triferic" or generic name "Ferric Pyrophosphate Citrate"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 57278-314 | Triferic | FERRIC PYROPHOSPHATE |
| 57278-315 | Triferic | FERRIC PYROPHOSPHATE CITRATE |
| 57278-316 | Triferic | Ferric Pyrophosphate Citrate |
| 64811-315 | Triferic | FERRIC PYROPHOSPHATE CITRATE |
| 57278-318 | Triferic AVNU | ferric pyrophosphate citrate |
| 60940-029 | Triferic AVNU | ferric pyrophosphate citrate |
| 60940-022 | Triferic Solution for Hemodialysis | ferric pyrophosphate citrate |
Trademark Results [Triferic]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 TRIFERIC 86036014 4837260 Live/Registered |
ROCKWELL MEDICAL, INC. 2013-08-13 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.